Bassam R Ali Selected Research

Bassam R Ali Research Topics

Disease

6	Intellectual Disability (Idiocy) 04/2017 - 07/2014
5	Hemoglobinopathies 01/2019 - 03/2016
4	Thalassemia 01/2019 - 03/2016
4	Sickle Cell Anemia (Hemoglobin S Disease) 10/2017 - 03/2016
3	Hereditary Hemorrhagic Telangiectasia 01/2024 - 01/2020
3	COVID-19 11/2023 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 01/2021
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2023 - 11/2019
3	Neoplasms (Cancer) 09/2022 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
3	Obesity 01/2021 - 01/2021
3	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 12/2019 - 07/2014
2	Disease Progression 11/2023 - 11/2023
2	Infections 01/2022 - 10/2013
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 04/2014
2	Pulmonary Arterial Hypertension 01/2020 - 04/2015
2	Robinow Syndrome 12/2019 - 11/2007
2	beta-Thalassemia (Cooley's Anemia) 01/2019 - 10/2017
2	Dysequilibrium syndrome 01/2018 - 12/2014
2	Autism Spectrum Disorder 01/2017 - 01/2017
2	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2017 - 01/2017
2	Microcephaly 06/2015 - 06/2013
1	Alcoholic Fatty Liver 05/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Maroteaux type Acromesomelic dysplasia 01/2023
1	Depressive Disorder (Melancholia) 01/2023
1	Cough 01/2023
1	Angioedema 01/2023
1	Bradycardia 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Vascular Malformations 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Type I Schindler Disease 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Familial Exudative Vitreoretinopathies 12/2019
1	Hemorrhage 10/2019
1	Hereditary Corneal Dystrophies 01/2018
1	Hydrocephalus (Hydrocephaly) 01/2018
1	Developmental Bone Diseases (Bone Dysplasia) 01/2018
1	Hydrops Fetalis (Fetal Edema) 01/2018
1	Strudwick syndrome 01/2018
1	Desbuquois syndrome 07/2017
1	Cardiotoxicity 05/2017

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 05/2023 - 07/2010
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2016
8	EnzymesIBA 11/2023 - 12/2009
6	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019 - 03/2016
4	EndoglinIBA 01/2024 - 01/2011
3	oxidized low density lipoproteinIBA 05/2023 - 01/2020
3	Fetal Hemoglobin (Hemoglobin F)IBA 01/2019 - 03/2016
3	Proteoglycans (Proteoglycan)IBA 07/2017 - 07/2011
2	Peptide Hydrolases (Proteases)FDA Link 11/2023 - 10/2022
2	LDL Receptors (LDL Receptor)IBA 05/2023 - 11/2019
2	Cytochrome P-450 CYP2C19IBA 01/2023 - 10/2019
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2023 - 01/2023
2	AnthracyclinesIBA 01/2021 - 05/2017
2	muskIBA 12/2019 - 03/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2019 - 03/2015
2	VLDL LipoproteinsIBA 01/2018 - 12/2014
2	LigandsIBA 01/2018 - 01/2018
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017 - 01/2017
2	NucleotidesIBA 11/2015 - 06/2013
1	Endoplasmic Reticulum Chaperone BiPIBA 05/2023
1	BradykininIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Natriuretic PeptidesIBA 01/2023
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	CarboxypeptidasesIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	AntigensIBA 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	CeramidesIBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	SteroidsIBA 01/2021
1	CholesterolIBA 01/2021
1	alpha-N-Acetylgalactosaminidase (N-Acetyl-alpha-D-Galactosaminidase)IBA 01/2020
1	OligosaccharidesIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 12/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	GlobinsIBA 10/2017
1	nucleotidaseIBA 07/2017
1	UDP Xylose-Protein XylosyltransferaseIBA 07/2017
1	Uridine Diphosphate XyloseIBA 07/2017
1	Serine (L-Serine)FDA Link 07/2017
1	CalciumIBA 07/2017

Therapy/Procedure

5	Therapeutics 09/2022 - 01/2011
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020